Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial

IMPORTANCE: Recent evidence indicates the efficacy of β-amyloid immunotherapy for the treatment of Alzheimer disease, highlighting the need to promote β-amyloid removal from the brain. Cilostazol, a selective type 3 phosphodiesterase inhibitor, promotes such clearance by facilitating intramural peri...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Satoshi, Suzuki, Keisuke, Ohtani, Ryo, Maki, Takakuni, Kowa, Hisatomo, Tachibana, Hisatsugu, Washida, Kazuo, Kawabata, Nobuya, Mizuno, Toshiki, Kanki, Rie, Sudoh, Shinji, Kitaguchi, Hiroshi, Shindo, Katsuro, Shindo, Akihiro, Oka, Nobuyuki, Yamamoto, Keiichi, Yasuno, Fumihiko, Kakuta, Chikage, Kakuta, Ryosuke, Yamamoto, Yumi, Hattori, Yorito, Takahashi, Yukako, Nakaoku, Yuriko, Tonomura, Shuichi, Oishi, Naoya, Aso, Toshihiko, Taguchi, Akihiko, Kagimura, Tatsuo, Kojima, Shinsuke, Taketsuna, Masanori, Tomimoto, Hidekazu, Takahashi, Ryosuke, Fukuyama, Hidenao, Nagatsuka, Kazuyuki, Yamamoto, Haruko, Fukushima, Masanori, Ihara, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696485/
https://www.ncbi.nlm.nih.gov/pubmed/38048134
http://dx.doi.org/10.1001/jamanetworkopen.2023.44938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696485/
https://www.ncbi.nlm.nih.gov/pubmed/38048134
http://dx.doi.org/10.1001/jamanetworkopen.2023.44938

Ejemplares similares